A multicenter, randomized, double-blind study on the efficacy and safety of Gongxuening capsules in reducing postoperative bleeding after induced abortio
Phase 4
- Conditions
- postoperative bleeding after induced abortion
- Registration Number
- ITMCTR2200005956
- Lead Sponsor
- Peking Union Medical College Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- Not specified
Inclusion Criteria
1. 20 years old = age = 40 years old;
2. Women with intrauterine pregnancy = 10 weeks and requiring termination of pregnancy without contraindications;
3. Regular menstrual cycle in the past half a year, no recent (half a year) history of induced abortion;
4. The subjects voluntarily signed the informed consent form.
Exclusion Criteria
1. Those who are allergic to the experimental drugs;
2. Subjects with contraindications to induced abortion;
3. Those with uterine malformation and large uterine fibroids;
4. Those with abnormal coagulation function who are using anticoagulant or hemostatic drugs;
5. Other circumstances judged by the investigator to be inappropriate for inclusion.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Vaginal bleeding volume;
- Secondary Outcome Measures
Name Time Method Complication;Safety index;Bleeding time;Endometrial repair;Menstrual rehydration time;